MetLife (MET) will release its quarterly results on Wednesday


MetLife (NYSE:MET – Get Rating) is set to release earnings data after market close on Wednesday, May 4. Analysts expect MetLife to post earnings of $1.62 per share for the quarter. Those interested in participating in the company’s earnings conference call can do so using this link.

MetLife (NYSE:MET – Get Rating) last released its results on Wednesday, February 2. The financial services provider reported EPS of $2.17 for the quarter, beating analyst consensus estimates of $1.42 by $0.75. MetLife had a net margin of 9.22% and a return on equity of 11.96%. The company posted revenue of $20.21 billion for the quarter, versus $17.67 billion expected by analysts. During the same quarter last year, the company achieved EPS of $2.03. The company’s revenue fell 1.8% from the same quarter last year. On average, analysts expect MetLife to post EPS of $7 for the current fiscal year and EPS of $8 for the next fiscal year.

MET stock opened at $66.72 on Wednesday. The company’s 50-day moving average price is $68.58 and its two-hundred-day moving average price is $65.89. MetLife has a 12-month low of $55.21 and a 12-month high of $73.18. The stock has a market capitalization of $55.05 billion, a price/earnings ratio of 9.11, a PEG ratio of 1.35 and a beta of 1.18. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt ratio of 0.22.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 14. Investors of record on Tuesday, May 10 will receive a dividend of $0.50 per share. This represents an annualized dividend of $2.00 and a dividend yield of 3.00%. This is a boost from MetLife’s previous quarterly dividend of $0.48. MetLife’s payout ratio is currently 26.23%.

Separately, Executive Vice President Steven J. Goulart sold 56,857 shares of the company in a transaction that took place on Tuesday, February 8. The shares were sold at an average price of $70.29, for a total transaction of $3,996,478.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this hyperlink. 0.20% of the shares are held by insiders.

A number of hedge funds have recently changed their positions in the business. EP Wealth Advisors LLC increased its stake in MetLife by 11.4% during the fourth quarter. EP Wealth Advisors LLC now owns 6,535 shares of the financial services provider valued at $408,000 after buying an additional 667 shares in the last quarter. NewEdge Advisors LLC increased its stake in MetLife by 122.0% during the fourth quarter. NewEdge Advisors LLC now owns 24,950 shares of the financial services provider valued at $1,560,000 after buying an additional 13,711 shares in the last quarter. Kingsview Wealth Management LLC acquired a new stake in MetLife during the fourth quarter valued at approximately $266,000. Zullo Investment Group Inc. acquired a new stake in MetLife during the fourth quarter valued at approximately $114,000. Finally, Deutsche Bank AG increased its stake in MetLife by 22.2% during the fourth quarter. Deutsche Bank AG now owns 3,402,992 shares of the financial services provider valued at $212,652,000 after buying an additional 617,275 shares in the last quarter. 88.85% of the shares are held by institutional investors and hedge funds.

Several stock analysts have recently released reports on the stock. Morgan Stanley raised its price target on MetLife shares from $76.00 to $79.00 and gave the company an “overweight” rating in a Tuesday, Feb. 22 research report. Wells Fargo & Company lowered its price target on MetLife stock from $75.00 to $74.00 and set an “overweight” rating on the stock in a Tuesday, Jan. 4 research note. UBS Group raised its price target on MetLife shares from $74.00 to $77.00 and gave the stock a “buy” rating in a Wednesday, January 12 research note. Barclays raised its price target on MetLife shares from $76.00 to $79.00 and gave the stock an “overweight” rating in a Tuesday, April 12 research note. Finally, JPMorgan Chase & Co. raised its price target on MetLife shares from $69.00 to $75.00 in a Tuesday, April 5 research note. One equity research analyst gave the stock a hold rating and thirteen gave the company’s stock a buy rating. According to MarketBeat, the stock currently has a consensus buy rating and an average target price of $74.14.

About MetLife (Get an assessment)

MetLife, Inc, a financial services company, provides insurance, annuity, employee benefits and asset management services worldwide. It operates through five segments: United States; Asia; Latin America; Europe, Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short and long term disability, individual disability, pet insurance, accidental death and dismemberment, vision, accident and sickness, and prepaid legal plans; administrative service arrangements only to employers; and general and separate accounts, and synthetic guaranteed interest contracts, as well as floating rate private financing agreements.

Featured articles

Earnings history for MetLife (NYSE:MET)



Get news and reviews for MetLife Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for MetLife and related companies with MarketBeat.com’s free daily email newsletter.

Comments are closed.